1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
132.02 -1.53 (-1.15%)
1.2M
XNAS Volume

XNAS 18 Jun, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 22 analysts

Repligen Corp has a share price target of US$ 176, revenue growth forecast of 11.5%, and profit growth estimate of 25.0% for FY26, based on top 22 analyst calls.